Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation

Diabetes

Volumn 49, Issue 6, 2000, Pages 889-895

  Bossenmaier, Birgit ^a   Strack, Volker ^b   Stoyanov, Borislav ^b   Krützfeldt, Jan ^b   Beck, Alexander ^b   Lehmann, Rainer ^b   Kellerer, Monika ^b   Klein, Harald ^c   Ullrich, Axel ^b   Lammers, Reiner ^b   Häring, Hans Ulrich ^b,c  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; DOCKING PROTEIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPEPTIDE; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL LYSATE; CELL STRAIN 3T3; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0034074152     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.6.889     Document Type: Article

References (29)

1. White MF, Haring HU, Kasuga M, Kahn CR: Kinetic properties and sites of autophosphorylation of the partially purified insulin receptor from hepatoma cells. J Biol Chem 259:255-264, 1984
2. Miele C, Caruso M, Calleja V, Auricchio R, Oriente F, Formisano P, Condorelli G, Cafieri A, Sawka-Verhelle D, VanObberghen E, Beguinot F: Differential role of insulin receptor substrate (IRS)-1 and IRS-2 in L6 skeletal muscle cells expressing the Arg1152→ Gln insulin receptor. J Biol Chem 274:3094-3102, 1999
3. Wolf G, Trub T, Ottinger E, Groninga L, Lynch A, White MF, Miyazaki M, Lee J, Shoelson SE: PTB domains of IRS-1 and She have distinct but overlapping binding specificities. J Biol Chem 270:27407-27410, 1995
4. Kasuga M, Zick Y, Blith DL, Karlsson FA, Haring HU, Kahn CR: Insulin stimulation of phosphorylation of the beta subunit of the insulin receptor: formation of both phosphoserine and phosphotyrosine. J Biol Chem 257:9891-9894, 1982
5. Lewis RE, Cao L, Perregaux D, Czech MP: Threonine 1336 of the human insulin receptor is a major target for phosphorylation by protein kinase C. Biochemistry 29: 1807-1813, 1990
6. Lewis RE, Wu GP, MacDonald RG, Czech MP: Insulin-sensitive phosphorylation of serine 1293/1294 on the human insulin receptor by a tightly associated serine kinase. J Biol Chem 265:947-954, 1990
7. Coghlan MP, Pillay TS, Tavare JM, Siddle K: Site-specific anti-phosphopeptide antibodies: use in assessing insulin receptor serine/threonine phosphorylation state and identification of serine-1327 as a novel site of phorbol ester-induced phosphorylation. Biochem J 303:893-899, 1994
8. Al-Hasani H, Eisermann B, Tennagels N, Magg C, Passlack W, Koenen M, Muller WD, Meyer HE, Klein MW: Identification of Ser-1275 and Ser-1309 as autophosphorylation sites of the insulin receptor. FEBS Lett 400:65-70, 1997
9. Liu F, Roth RA: Identification of serines-1035/1037 in the kinase domain of the insulin receptor as protein kinase C alpha mediated phosphorylation sites. FEBS Lett 352:389-392, 1994
10. Liu F, Roth RA: Identification of serines-967/968 in the juxtamembrane region of the insulin receptor as insulin-stimulated phosphorylation sites. Biochem J 298:471-477, 1994
11. Feener EP, Backer JM, King GL, Wilden PA, Sun XJ, Kahn CR, White MF: Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J Biol Chem 268:11256-11264, 1993
12. Berti L, Mosthaf L, Kroder G, Kellerer M. Tippmer S, Mushack J, Seffer E, Seedorf K, Haring HU: Glucose-induced translocation of protein kinase C isoforms in rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem 269:3381-3386, 1994
13. Bossenmaier B, Mosthaf L, Mischak H, Ullrich A, Haring HU: Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia 40:863-866, 1997
14. Kellerer M, Mushack J, Seffer E, Mischak H, Ullrich A, Haring HU: Protein kinase C isofonns alpha, delta and theta require insulin receptor substrate-1 to inhibit the tyrosine kinase activity of the insulin receptor in human kidney embryonic cells (HEK 293 cells). Diabetologia 41:833-838, 1998
15. Mosthaf L, Berti L, Kellerer M, Mushack J, Seffer E, Bossenmaier B, Coghlan M, Siddle K, Ulrich A, Haring HU: C-terminus or juxtamembrane deletions in the insulin receptor do not affect the glucose-dependent inhibition of the tyrosine kinase activity. Eur J Biochem 227:787-791, 1995
16. Strack V, Bossenmaier B, Stoyanov B, Mosthaf L, Kellerer M, Lanumers R, Häring HU: The inhibitory effect of 2-deoxyglucose on insulin receptor autophosphorylation does not depend on known serine phosphorylation sites or other conserved serine residues of the receptor β-subunit. FEBS Lett 449:111-114, 1999
17. Strack V, Hennige AM, Krützfeldt J, Bossenmaier B, Klein HH, Kellerer M, Lammers R, Häring HU: Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms β2 and θ. Diabetologia 43:443-449, 2000
18. Kunkel TA, Roberts JD, Zakour RA: Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol 154:367-382, 1987
19. Lammers R, Bossenmaier B, Cool DE, Tonks NK, Schlessinger J, Fischer EH, Ullrich A: Differential activities of protein tyrosine phosphatases in intact cells. J Biol Chem 268:22456-22462, 1993
20. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752, 1987
21. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990, 1989
22. Landau NR, Littman DR: Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol 66:5110-5113, 1992
23. Morgan SJ, Smith AD, Parker PJ: Purification and characterization of bovine brain type I phosphatidylinositol kinase. Eur J Biochem 191:761-767, 1990
24. Klein HH, Kowalewski B, Drenckhan M, Fehm HL: Insulin stimulation of human adipocytes activates the kinase of only a fraction of the insulin receptors. Am J Physiol 272-E576-E583, 1997
25. White MF, Shoelson SE, Keutmann H, Kahn CR: A cascade of tyrosine autophosphorylation in the β-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 263:2969-2980, 1988
26. Krook A, O'Rahilly S: Mutant insulin receptors in syndromes of insulin resistance. Baillieres Clin Endocrinol Metab 10:97-122, 1996
27. Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli G, Ferrara A, Pianese L, Miele C, Capaldo B, Beguinot F: NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes 41:521-526, 1992
28. Formisano P, DeNovellis G, Miele C, Tripodi F, Caruso M, Palumbo G, Beguinot L, Beguinot F: Internalization of the constitutively active arginine 1152 → glutamine insulin receptor occurs independently of insulin at an accelerated rate. J Biol Chem 269:16242-16246, 1994
29. Hubbard SR, Wei L, Ellis L, Hendrickson WA: Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-754, 1994